Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release …

M Teymouri, A Badiee, S Golmohammadzadeh… - International journal of …, 2016 - Elsevier
We have investigated the co-addition of hexadecylphosphocholine (HePC) and a Tat
derived peptide (Tat), coupled to Maleimide-PEG2000-DSPE pegylated liposomal
doxorubicin (PLD) in many respects, including drug and liposome cellular delivery, drug
release, biodistribution, in vivo cell delivery and antitumor activity. The liposomes were
HePC-free and-containing liposomes, from which liposomes with 25, 50, 100 and 200
numbers of Tat/liposome were prepared. Similarly, DiI-C18 (3)-model liposomes (DiI-L and …

[PDF][PDF] Tat peptide and Hexadecylphosphocholine introduction

MTAB Shiva - International journal of pharmaceutics, 2016 - academia.edu
We have investigated the co-addition of Hexadecylphosphocholine (HePC) and a Tat
derived peptide (Tat), coupled to Maleimide-PEG2000-DSPE Pegylated liposomal
doxorubicin (PLD) in many respects, including drug and liposome cellular delivery, drug
release, biodistribution, in vivo cell delivery and antitumor activity. The liposomes were
HePC–free and-containing liposomes, from which liposomes with 25, 50, 100 and 200
numbers of Tat/liposome were prepared. Similarly, DiI-C18 (3)-model liposomes (DiI-L and …
以上显示的是最相近的搜索结果。 查看全部搜索结果